How To Spur Scientific Revolution: Amass Copious Data, Keep It Simple

It's another late night in the lab, and you are poring over a data set that just doesn't make sense. No matter how you crunch the numbers, they just don't fit. Unless. . . . If you disregard the generally accepted model and ignore the ideology of the day, an intriguing mechanism emerges. Your midnight model explains all the data, but it runs counter to everything you've been taught about biology. You'd be in good company. In the past, scientists have grappled with some seemingly bizarre concep

Written byKaren Hopkin
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

It's another late night in the lab, and you are poring over a data set that just doesn't make sense. No matter how you crunch the numbers, they just don't fit. Unless. . . . If you disregard the generally accepted model and ignore the ideology of the day, an intriguing mechanism emerges. Your midnight model explains all the data, but it runs counter to everything you've been taught about biology.

You'd be in good company. In the past, scientists have grappled with some seemingly bizarre concepts: DNA that jumps around the genome; RNA that catalyzes a molecular reaction; proteins that may behave like genetic material. But they stood by their ideas, secured funds, and managed to amass enough evidence to win over even their most dubious critics-in some cases, receiving a Nobel Prize for their efforts.

How did they manage to turn alternative theories into something mainstream? And what ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies